The HemOnc Pulse cover image

Holding the Line in AML: Real-World Care Meets Breakthrough Trials

The HemOnc Pulse

00:00

NPM1 biology and risk profile

Eunice Wang explains NPM1's favorable classification, its limits, and relapse risks in AML.

Play episode from 00:43
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app